iX Biopharma Ltd. (SGX:42C)

Revenue by Product

Financials in millions SGD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014
Specialty Pharmaceutical	5.45M
Specialty Pharmaceutical Growth	5.56%
Nutraceutical	508.00K
Nutraceutical Growth	-32.18%

Revenue by Geography

Financials in millions SGD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014
Australia	5.47M
Australia Growth	6.70%
China	408.00K
China Growth	-29.53%
Singapore	81.00K
Singapore Growth	-30.77%
United States	5.00K
United States Growth	-94.74%